Внутренний голос. Почему мы говорим с собой и как это на нас влияет

_{11. Отличное описание психологических приемов, объясняющих, почему разумные люди верят в сверхъестественное, см. в статье Jane Risen “Believing What We Do Not Believe: Acquiescence to Superstitious Beliefs and Other Powerful Intuitions,” Psychological Review 123 (2016): 182–207.}

_{12.Yoni K. Ashar, Luke J. Chang and Tor D. Wager. “Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account,” Annual Review of Clinical Psychology 13 (2017): 73–98; Ted J. Kaptchuk and Franklin G. Miller. “Placebo Effects in Medicine,” New England Journal of Medicine 373 (2015): 8–9; и Tor D. Wager and Lauren Y. Atlas. “The Neuroscience of Placebo Effects: Connecting Context, Learning and Health,” Nature Reviews Neuroscience 16 (2015): 403–418.}

_{13. Ted J. Kaptchuk et al. “Components of Placebo Effect: Randomized Controlled Trial in Patients with Irritable Bowel Syndrome,” British Medical Journal 336 (2008): 999–1003.}

_{14.Karin Meissner et al. “Differential Effectiveness of Placebo Treatments: A Systematic Review of Migraine Prophylaxis,” JAMA Internal Medicine 173 (2013): 1941–1951.}

_{15.Michael E. Wechsler et al. “Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma,” New England Journal of Medicine 365 (2011): 119–126.}

_{16. Например, см.: Andrew L. Geers et al. “Dispositional Optimism Predicts Placebo Analgesia,” The Journal of Pain 11 (2010): 1165–1171; Marta Pecina et al. “Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates,” Neuropsychopharmacology 38 (2013): 639–646.}

_{17. C. Warren Olanow et al. “Gene Delivery of Neurturin to Putamen and Substantia Nigra in Parkinson Disease: A Double-Blind, Randomized, Controlled Trial,” Annals of Neurology 78 (2015): 248–257. Дополнительную информацию, подтверждающую эффективность плацебо при лечении болезни Паркинсона, см. в статьях: Raul de la Fuente-Fernandez et al. “Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson’s Disease,” Science 293 (2001): 1164–1166; Christopher G. Goetz. “Placebo Response in Parkinson’s Disease: Comparisons Among 11 Trials Covering Medical and Surgical Interventions,” Movement Disorders 23 (2008): 690–699; American Parkinson Disease Association. “The Placebo Effect in Clinical Trials in Parkinson’s Disease,” March, 6, 2017, www.apdaparkinson.org/article/the-placebo-effect-in-clinical-trials-in-parkinsons-disease/.}